chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I developed shingles 2 days after getting the 1st dose of Pfizer vaccine.; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), first dose via an unspecified route of administration, administered in left arm on 13Mar2021 at 13:00 (at the age of 74-year-old) as dose 1, single for COVID-19 immunisation at military base. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP, hypertension from an unknown date and unknown if ongoing Other medical history: High cholesterol, high BP. No known allergies were reported. The patient's concomitant medications in two weeks of COVID-19 vaccination included blood pressure, cholesterol, multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that on 16Mar2021, the patient developed shingles 2 days after getting the 1st dose of Pfizer vaccine. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Unspecified medication was given as treatment for the events. The outcome of the event was reported as resolved with lasting effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a registered nurse refers to a 16 year old female patient. The patient has chronic syncope and headache which started in April 2009. The patient had no drug reactions or allergies. On 22-APR-2009, the patient was vaccinated with first dose of GARDASIL, (lot number, expiry date was unknown, route was intramuscular). On 01-JUL-2013, the patient was vaccinated with second dose of 0.5 ml GARDASIL (lot number was H021346, expiry date was 01-oct-2015 and the route was intramuscular). Concomitant therapies included adapalene, EPIDUO. Since 2009, the patient has been suffering from recurrent headaches and syncopal episodes. Treatment was unspecified. After the second dose the patient experienced headache, weakness, her ears were ringing, chills and nausea. On morning of 02-JUL-2013, the patient fainted and was seen in the emergency room but she was not admitted to hospital. All the lab work was within normal limits. The patient was given intravenous bolus 0.9 percent. Urinalysis drug screen, chest x ray and beta group a streptococcal screen all were in within normal limits. The outcome of the reported events were unknown. The patient sought medical attention. Additional information has been requested.
Left upper thigh, swollen red and tender to to the touch.Redness goes two inches wide on both sides of immunization spot.
I have had an extremely heavy and painful menstrual cycle. This is extremely abnormal for me as a I have been on the Mirena IUD contraceptive for years and  have consistently not had a menstrual cycle. This is the first cycle I have had in years and it has only been 2 weeks since I received the first  dose of the Pfizer vaccine.
Nausea, diarrhea, vomiting, fever of 99.5, mild flu-like symptoms.
Swelling and pain around the area of the left forearm near the elbow joint, these symptoms lasted a day and a half. Patient was instructed by the on-call doctor to use cold compresses. She was not hospitalized.
I have been diagnosed with Gout by a MD doctor.  The gout appeared 18 hours after receiving the Flu vaccine.
Swollen Arm, Dizziness, Headachess, Redness at injection site
I came down with a sore throat and then ended up with a significant head cold type symptoms, congestion, runny nose, fever, head fog. I self tested for COVID-19 and tested positive on 11/17. It started on a Thursday, but on the following Monday the brain fog lifted but I started getting a lot of congestion and couldn't stopped coughing. I went to the urgent care and they prescribed something for the cough and prednisone for the inflammation in my lungs. I took those for the five days and it improved. The cough lingered for a couple of weeks but I have finally regained my health again. After 10 days I still had a faint line on the positive test, but didn't test again after that and followed CDC guidelines for isolating for 5 days and masks for 5 days in public.
Felt like a bus hit; Couldn't move; Extreme high blood pressure; Blur vision; Dehydrated; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt like a bus hit), MOBILITY DECREASED (Couldn't move), HYPERTENSION (Extreme high blood pressure), VISION BLURRED (Blur vision) and DEHYDRATION (Dehydrated) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PANTOPRAZOLE and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt like a bus hit), MOBILITY DECREASED (Couldn't move), HYPERTENSION (Extreme high blood pressure), VISION BLURRED (Blur vision) and DEHYDRATION (Dehydrated). At the time of the report, FEELING ABNORMAL (Felt like a bus hit), MOBILITY DECREASED (Couldn't move), HYPERTENSION (Extreme high blood pressure), VISION BLURRED (Blur vision) and DEHYDRATION (Dehydrated) outcome was unknown.            Treatment included IV Saline drip for dehydration
After receiving the vaccination 10 to 15 min later my head started hurting, pain in my chest area, and stomach pain. I also couldn't focus and I was experiencing vision problems meaning I had trouble seeing. All these problems I wasn't experiencing any of them before the ??. I wasn't watching the time but everything lasted till I made it home and took my pain medication. If more information is needed please feel free to reach out to me.
Fever 102.4(R) & refused to eat. Stayed @ 101(R) w/tylenol Saw MD 16FEB91. Dx as having URI. Fever attributed to immunization. 0 meds.
This spontaneous report as received from a healthcare worker referring to unspecified number of patients. On unknown dates ranging from 15-JUN-2015 through 07-DEC-2015 the patients were vaccinated with improperly stored GARDASIL (dose and route not reported, lot # K011562, expired date: 10-MAY-2017; J015378, expired date: 09-APR-2016). No adverse event reported. This is one of the several reports from the same reporter. Additional information has been requested.
No adverse reaction report at time of error- 0.5 ml given instead of 0.3 ml
Reported that she received the Moderna vaccine 12/30/2020. As of 1/7/2020 the employee began to itch at the injection site and it became red and warm to touch. The area of redness was 6 inches by 3 inches. Redness was blanchable. Employee marked the areas and reports that it did not extend. Reported that during the day it became less red. Employee sent photo of rash. Employee was advised on how to monitor and manage symptoms.
Received Pfizer vaccines on 1/4/21, 1/27/21. Tested positive for COVID-19 by PCR on 5/22/21. No known exposures. Onset date of symptoms 5/20/21 w/ fever, diarrhea, H/A, chills. Received casirivimab-imdevimab 2,400 mg (1,200-1,200 mg) IVPB  on 5/24/21.
Information has been received from an LPN concerning a 12 month old pt who on 9/17/01 was vaccinated with a dose of MMRII. Five or six days, post vax, on approx. 9/22/01, the pt broke out in spots. The LPN reported that she does not know if rash was all over the body but reported that the spots/rash was starting to spread to the child's face. Unspecified medical attention was sought. Additional information has been requested.
I was sick for ten days before getting the flu shot at the drs office. I was seeing the dr for a viral infection that wouldn?t clear and was given the flu shot that day which they said was safe while I was ill as long as I didn?t have a fever which I did not currently.   I was admitted to the hospital 8 days later and diagnosed with thrombocytopenia with platelets less than 5k and to this day after many treatments I still have a low platelet count. They now are staying between 80-100k but that?s after taking steroids, doing IVIG twice and 4 rounds of rituxan.
Patient was given Hepatitis A and VARIVAX; within minutes was syncopal and had tonic-clonic seizure while still in exam room. Pulse 70, B/P 104/62. Observed x 15 minutes, then had a 2nd tonic clonic seizure for 1-2 minutes at the check out desk. Responsive afterward, but very weak - transported to ER. Had similar experience after vaccines given 01/06.
Was vaccinated with your covid 19 vaccine, receiving my final shot back in May. I recently was diagnosed with covid 19; Was vaccinated with your covid 19 vaccine, receiving my final shot back in May. I recently was diagnosed with covid 19; This is a spontaneous report received from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date: Not reported), via an unspecified route of administration in May2021 as dose 2, single; and received first dose of BNT162B2 (Batch/Lot number and Expiration date: Not reported), via an unspecified route of administration on an unspecified date as dose 1, single; both for covid-19 immunization. Medical history and concomitant medications were not reported. It was reported that patient was vaccinated with COVID-19 vaccine, and received final shot back in May. Patient recently was diagnosed with COVID-19 on an unspecified date in 2021. Treatment received for event was unknown. Patient was unsure if there are any studies or anything that patient may be able to donate blood samples or anything similar to in order to help better the vaccine or any potential boosters. The patient underwent lab tests and procedures which included sars-cov-2 test, resulted as diagnosed with COVID-19 on an unspecified date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
presented to ED 3/22/21 with leg swelling that worsened over past 2 days. Diagnosed with Venous stasis ulcers & Thrombocytopenia
Immediately during and after the shots, she was crying. Right after, she was very tired and drowsy. She fell asleep in the car on the way home. Napped for a very short time during the evening and was kind of fussy which was not normal for her. She was fed at around 9:30 PM that evening and fell asleep right after so she was laid down on her back in her crib. She was checked on at 11:30 and 12, still sleeping on her side. She was checked on at 6 the following morning and was face down. When she was flipped over she was all blue/discolored with fluids coming out of her nose. When EMS arrived, no resuscitation attempts were made.
Site: Pain at Injection Site-Mild, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypertension-Mild, Additional Details: Patient reported that he had difficulty hearing. Patient sat in the chair and then lost conciousness. He was laid down on the ground, vitals were checked, and water was given. Noted high blood pressure. Patient regained conciousness within 3-5 minutes. Vitals were rechecked and returned to normal.
I95.9 HYPOTENSION 4/13/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
This spontaneous report as received from a healthcare worker via a representative refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with an expired dose of M-M-R II (lot#, strength, dosage and route unknown). No adverse effect reported. Additional information has been requested.
Vaccination given on 9/22/11. No symptoms that day or 9/23/11. First symptoms at 7AM on 9/24/11. Swelling of left wrist & hand and intense pain in wrist & progressive weakness of wrist & hand ultimately leading to paresthesia of fingers & hand with continued intense pain. Symptoms began to regress in 48 hours. Some weakness of hand & wrist still persist - the feeling returned.
Wheezing, chest pressure, racing heart, coughing - 45 minutes later, better with water and cough drops, pressure still in chest.
I had a dry cough, sore throat, no fever, I tested on Friday with a home COVID-19 test it was negative. On Saturday I tested again and it was positive, I went in to the local urgent care, they tested and it came back positive. They gave me a prescription for PAXLOVID that I started that night. I still have nasal congestion and am not completely one hundred percent myself.
A little swollen in the arm which lasted for an hour or two.; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (A little swollen in the arm which lasted for an hour or two.) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis (Has severe psoriatic arthritis for 22 years). Concomitant products included IXEKIZUMAB (TALTZ) for Psoriatic arthritis, PREDNISONE and OXYCODONE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (A little swollen in the arm which lasted for an hour or two.). At the time of the report, PERIPHERAL SWELLING (A little swollen in the arm which lasted for an hour or two.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that she has been on 9 different biologic medicines. Treatment information was not provided.   This case was linked to MOD-2021-318127, MOD-2021-318145, MOD21-142970 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2021: Follow up received contains no new information On 15-Sep-2021: Follow up contains no new information please confirm as NNI.
This case was reported by a consumer via call center representative and described the occurrence of heart disorder in a adult male patient who received RABAVERT (batch number 628011A, expiry date 30th April 2020) and (batch number 627011A, expiry date 31st March 2020). On an unknown date, the patient received RABAVERT. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving RABAVERT, the patient experienced heart disorder and weakness. On an unknown date, the outcome of the heart disorder and weakness were unknown. It was unknown if the reporter considered the heart disorder and weakness to be related to RABAVERT. Additional details were provided as follows: The caller was a scientist and was not considerd a healthcare professional. The age at the vaccination was not reported. The patient reported that he received the Rabies vaccine and that he had a bad heart and was weak. It was unknown if the patient received RABIPUR vaccination for pre or post exposure prophylaxis. Attempted to clarify the timing of symptom development and when the patient received the vaccine and he refused to provide the information. The report was filed with limited information provided during the call as unable to verify demographic information or collect any further details for this report. The caller was asking for safety information about the lot numbers provided above.
"Red, raised and itchy" per SM and, some reported it to FOB sick call on 5/16/07 recommendation for anthrax route
Rash around injection site; Could not think straight / described as decreased cognitive ability; Night sweats; Labored breathing; slurred speech; difficulty sleeping; Llegs felt very heavy / hard to move; joint pain; Pain at the injection site; Malaise; Fatigue; Llegs felt very heavy / hard to move; Pain above the rib cage; This case was reported by a consumer and described the occurrence of injection site pain in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th December 2020, the patient received the 1st dose of Shingrix (intramuscular). On 15th December 2020, immediately after receiving Shingrix, the patient experienced injection site pain, malaise, fatigue, heaviness in leg, chest pain, joint pain and mobility decreased. On 16th December 2020, the patient experienced cognitive disturbance, night sweat, labored breathing, slurred speech and difficulty sleeping. On 17th December 2020, the patient experienced injection site rash. On 15th December 2020, the outcome of the injection site pain was recovering/resolving. On an unknown date, the outcome of the malaise, fatigue, heaviness in leg, chest pain, cognitive disturbance, night sweat, labored breathing, injection site rash, joint pain, slurred speech, mobility decreased and difficulty sleeping were unknown.   It was unknown if the reporter considered the injection site pain, malaise, fatigue, heaviness in leg, chest pain, cognitive disturbance, night sweat, labored breathing, injection site rash, joint pain, slurred speech, mobility decreased and difficulty sleeping to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix at physician's office and immediately felt pain at the injection site.  Two hours later, the patient experienced malaise and fatigue and reported that his legs felt very heavy and hard to move.  The patient experienced pain above the rib cage.  The patient could not think straight, described as decreased cognitive ability. The patient had joint pain and slurred speech. The patient experienced night sweats and difficulty sleeping and experienced labored breathing.   2 days later, the patient had rash appeared around the injection site.  The reporter consented to follow up.
administered only the liquid portion; administered only the liquid portion. This was the 2nd dose; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA747A, expiry date 31st October 2023) for prophylaxis.   On 7th October 2022, the patient received the 2nd dose of Menveo. On 7th October 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 11-OCT-2022 Reporter's comment:  Medical Assistant stated that she inadvertently administered only the liquid portion of the Menveo to a patient. This was the patient's second dose and the error occurred because Medical Assistant stated she was in a rush, running behind, and was not familiar with Menveo administration (she typically administers Menactra or Menquadfi, which only have one vial). No further details provided. The reporter was consented to follow up. Additional Supportive Information: The patient administered only the liquid portion of the Menveo, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.
Diarrhea; Dizziness; Pain; Headache; Fatigue; Nausea; Possible fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), GABAPENTIN, ALPRAZOLAM (XANAX), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), PAIN (Pain), HEADACHE (Headache), FATIGUE (Fatigue), NAUSEA (Nausea) and PYREXIA (Possible fever). At the time of the report, DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), PAIN (Pain), HEADACHE (Headache), FATIGUE (Fatigue), NAUSEA (Nausea) and PYREXIA (Possible fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a pharmacist concerning an adult male who on approximately 9/2/04 was vaccinated with a dose of varicella virus vaccine live. Concomitant therapy included Acyclovir. Subsequently, the patient developed chicken pox and was hospitalized. No other information was available. The outcome was reported as recovering. There was no product quality complaint. Additional information has been requested.
Moderate to severe chest pain for 3 days after injection. Chest rash for 3 days after injection. Injection site pain for 2 days after injection. Severe fatigue for 3 days after injection.
Subsequent to receiving one dose of varicella virus vaccine live, pt was presented to a physician who diagnosed her with chickenpox. It was indicated that some lesions were infected. Pt was treated with Keflex.
Tested positive for COVID-19 after 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after 1st dose of the vaccine) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after 1st dose of the vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after 1st dose of the vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, SARS-CoV-2 test: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Moderna COVID-19 Vaccine EUA Painful, swollen lymph node in armpit of vaccinated arm.  Pain began evening of day 5 post vaccine, swelling noticeable (difficult to wear usually loose Tshirt without pain and discomfort in the armpit region) evening of day 6 post vaccine. Pain treated with 400-600mg of IB Profen as needed for pain. Swelling diminished evening of day 8 post vaccine. Pain diminished evening of day 9 post vaccine.
Shingles vaccine received January 2019. Next morning, unable to weight bear on legs without great pain. Muscle and bone pain. Lasted 24 hours. One month later broke out with actual case of shingles 2/15/19.
3RD DOSE COVID VACCINE, COMIRNATY, GIVEN 8/25/22, LOT #FP7138; pt brought to local hospital for AMS and SOB; positive for COVID; O2 supplementation eventually requiring intubation; given dexamethasone, remdesivir, monoclonal antibodies, bronchodilators; was able to be extubated 8/10/22; dry gangrene left foot; angiogram revealed chronic occluded SFA; ongoing dysphagia, PEG tube placed; 8/25/22 DC'd to local Health and Rehab Center where he passed away
Hiberix was not given with the diluent it comes with. Vaccines are not paired together with easy-to-read instructions.